Correlation Between Psychological Resilience and Genetic, Inflammatory Indicators
Launched by QIANFOSHAN HOSPITAL · Dec 21, 2023
Trial Information
Current as of August 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand how young people's ability to adapt to challenges is influenced by their genes and the environment around them. Researchers want to find out which factors are the most important for helping young people cope with difficulties, and how genetics and environmental factors work together to shape their psychological resilience. The study aims to develop a model that can predict changes in this adaptive ability over time and create a system to categorize young people based on their adaptability.
To participate in the trial, individuals must be between 18 and 24 years old, have completed high school or higher education, and agree to provide blood samples and sign consent forms. Participants will undergo assessments to measure their adaptability and provide information about their genetics and inflammation levels. The results will help researchers better understand how to support young people in developing strong coping skills. Please note that the study is not yet recruiting participants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18-24 years old; high school graduation and above; agree to collect blood samples and sign an informed consent form.
- Exclusion Criteria:
- • Did not consent to the collection of blood samples; did not sign an informed consent form; suffered from a major illness such as a malignant tumor.
About Qianfoshan Hospital
Qianfoshan Hospital is a leading medical institution dedicated to advancing healthcare through innovative clinical research and trials. Located in Shandong Province, China, the hospital is renowned for its commitment to excellence in patient care and medical education. With a multidisciplinary team of experienced professionals, Qianfoshan Hospital focuses on a wide range of therapeutic areas, striving to enhance treatment options and improve patient outcomes. The institution actively collaborates with various stakeholders to ensure the highest standards of ethics and efficacy in its clinical research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Guang Zhang, Dr
Principal Investigator
Qianfoshan Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported